A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who took the vitamin B3 derivative saw notable reductions in new cancer cases—especially squamous cell carcinomas.

A new study finds that vitamin B3 (nicotinamide) at 500 mg twice daily reduces basal cell carcinoma and squamous cell carcinoma risk in veterans over a 25-year period.

Could a daily vitamin B3 pill prevent skin cancer? New research finds nicotinamide cuts recurrence risk by more than half in high-risk patients.

Researchers at Wake Forest University's School of Medicine have developed a battery-free, chip-less wearable patch that can detect skin cancer early. According to the university, the patch is used to measure bioimpedance (the electrical properties of skin) to locate abnormalities.

A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for patients who have exhausted other options.

The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients with high-risk characteristics.